Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Investors with an eye on the healthcare sector might find The Pennant Group, Inc. (NASDAQ: PNTG) an intriguing prospect. Headquartered in Eagle, Idaho, Pennant operates within the Medical Care Facilities..
10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation within the healthcare sector, specifically in the health information services industry. Founded in 2012 and headquartered in Pleasanton, California,..
Astrana Health Inc. (ASTH) is making waves in the healthcare sector with promising growth prospects and a solid market position. With a current market capitalization of $1.48 billion, this Alhambra,..
Pulse Biosciences, Inc. (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine solutions. Operating primarily in the medical instruments and supplies industry, the company has..
Investors with an eye on the healthcare sector, particularly the medical device industry, may find Establishment Labs Holdings Inc (NASDAQ: ESTA) a compelling prospect. Headquartered in Alajuela, Costa Rica, this..
Azenta, Inc. (NASDAQ: AZTA) offers a compelling story for investors in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.4 billion and..
NeoGenomics, Inc. (NASDAQ: NEO), a key player in the diagnostics and research industry, presents a compelling opportunity for investors looking to tap into the healthcare sector. With a market capitalization..
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, offers investors an intriguing opportunity with a potential upside of 108.92%, according to analysts’ average target price. Specializing..
Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is capturing the attention of investors with its innovative approach to healthcare, particularly in the burgeoning field of biotechnology. With a market capitalization of $2.01..
Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, offers a compelling narrative for investors focused on the medical care facilities industry. Headquartered in Atlanta, Georgia, Aveanna..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), with its headquarters in Cambridge, Massachusetts, is a notable player in the biotechnology segment of the healthcare sector. The company is primarily focused on the..
Phreesia, Inc. (NYSE: PHR) stands as a notable player in the healthcare sector, particularly within the health information services industry. Known for its integrated SaaS-based software and payment platform, Phreesia..
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its innovative approach to developing oral small molecule therapeutics aimed at addressing chronic diseases..
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, focusing on the development and commercialization of treatments for central nervous system (CNS) diseases. With a market capitalization..
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a notable player in the healthcare sector, carving its niche within the drug manufacturing industry focusing on specialty and generic pharmaceuticals. With a..
Pacira BioSciences, Inc. (NASDAQ: PCRX) is a compelling player in the healthcare sector, specializing in non-opioid pain management and regenerative health solutions. With a market capitalization of $1.2 billion, this..
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine oncology, offering intriguing potential for investors seeking high-growth opportunities in the biotechnology sector. With a market capitalization of..
LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a prominent player in the medical instruments and supplies industry, and its recent financial performance underscores its potential as a compelling investment opportunity. With..
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a pioneering entity in the healthcare sector, has become a focal point of interest for investors seeking exposure to the specialty and generic drug manufacturing..
Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology firm specializing in neuroscience, has become a focal point for investors seeking significant growth potential. With its current stock price at $38.71..
